Clinical Trials

What is a decentralized clinical trial?

Image Description
Samantha Trolli

Published 15 Apr 2022 - Updated 15 Apr 2022

What is a decentralized clinical trial? - Infiuss Health

Share

Clinical trials have always been known to be executed in medical facilities. When the Covid-19 pandemic struck in 2020, much devastation occurred. The pandemic put a pause on many operations, including clinical trials. Clinical researchers needed to find a way to continue. This was done so by implementing a new upcoming way of research, decentralized clinical trials; Decentralized clinical trials are also referred to as DCT’s. The purpose of a DCT is to remove in-person contact between the study team and the patients/subjects. 
The benefits of DCT’s, are as listed:
  • Eliminating travel costs, distance, and extreme weather.
  • Avoiding absences of work for the participants/subjects.
  • Removing mobility challenges for the participants/subjects.
  • Increasing the demographic of participants/subjects.

One can see why the pandemic gave rise to a personalized and convenient form of research. Infiuss is joining the research revolution by utilizing the internet's ability to remove these obstacles to clinical trials (check out our blog: What Are The Benefits Of A Remote Platform For Clinical Trials?) Our goal is to promote the creation of DCT’s by providing a platform that allows access to create and participate in DCT’s. 
Clinical Trials Africa Infiuss Health Decentralized DCT

Find new health insights

Infiuss Health insights contains inspiring thought leadership on health issues and the future of health data management and new research.